Ptosis, diplopia and statins: an association?
Elsais
A
A
Lund
C
C
Kerty
E
E
D000328:Adult; D000069059:Atorvastatin; D001323:Autoantibodies / Q000097:blood / Q000276:immunology; D020274:Autoimmune Diseases of the Nervous System / Q000139:chemically induced* / Q000276:immunology; D001384:Azetidines / Q000627:therapeutic use; D001763:Blepharoptosis / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology; D048909:Diabetes Complications; D003951:Diagnostic Errors; D004172:Diplopia / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology; D005141:Eyelid Diseases / Q000175:diagnosis; D000069438:Ezetimibe; D006538:Heptanoic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D008297:Male; D009157:Myasthenia Gravis / Q000139:chemically induced*; D009203:Myocardial Infarction / Q000150:complications; D010146:Pain / Q000139:chemically induced* / Q000276:immunology; D017035:Pravastatin / Q000009:adverse effects*; D011758:Pyrroles / Q000009:adverse effects* / Q000627:therapeutic use; D011950:Receptors, Cholinergic / Q000276:immunology; D012008:Recurrence; D013285:Strabismus / Q000139:chemically induced / Q000601:surgery
D001323:Autoantibodies; D001384:Azetidines; D006538:Heptanoic Acids; D011758:Pyrroles; D011950:Receptors, Cholinergic; D000069059:Atorvastatin; D000069438:Ezetimibe; D017035:Pravastatin